- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Cigna Walks on Anthem; Kaiser Sticking With Exchanges; Counterfeit Rx Drugs
Cigna Wins Approval to Exit Anthem Deal
A Delaware judge has ruled that Cigna can walk away from its merger with Anthem after the courts blocked the merger for being anticompetitive. Bloomberg reported that the breakup of the $48 billion merger means Anthem could have to pay $1.85 billion in breakup fees to Cigna. In addition, Cigna is suing for $13 billion in damages. However, the judge said there is evidence Cigna may have dragged its feet making it unlikely it will win the lawsuit.
Kaiser Permanente to Remain in ACA Markets
While some insurers are fleeing the Affordable Care Act (ACA) exchanges, Kaiser Permanente will stay in the marketplace in 2018. During the Wall Street Journal Future of Healthcare event, CEO Bernard Tyson pledged to stick with the markets and rejected Aetna’s claim that the markets were in a death spiral. Kaiser Permanente currently operates health plans in exchanges in 8 states and the District of Columbia.
North Carolina Warns Against Counterfeit Drugs
A new campaign in North Carolina is warning residents about online pharmacies that could be selling counterfeit prescription drugs. Consumers can check the legitimacy of an online pharmacy through VerifyBeforeYouBuy.org, according to The News & Observer. Counterfeit drugs, which could be contaminated, might contain no medication, or contain just a small amount, present a health hazard to users.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
